Children of color who presented to pediatric EDs with headache were less likely to receive a migraine diagnosis than non-Hispanic White children and underwent less testing and imaging in a retrospective study.
In migraine patients who used barbiturates as part of their anti-migraine regimen, a significant decrease in use of these drugs was observed in the months following initiation of treatment with rimegepant.
Share this article
Share this article
IRVINE, Calif., Feb. 8, 2021 /PRNewswire/ The Migraine World Summit (MWS), an annual online event that offers hope, education, and support to people living with migraine and headache disease, will gather for its sixth year, March 17
th – 25
th, 2021. This free live stream event will feature interviews with 32 top experts, doctors, and specialists, and over 100,000 people are expected to attend from around the world.
World-Leading Headache Experts Share Resources and Hope During the Pandemic at the Upcoming Migraine World Summit
As our lives have been turned upside down by the COVID pandemic, there has been a troubling rise in the severity and occurrence of migraine attacks for 70% of people with migraine